We are live on ! Find out more
EGI

EAM Global Investors Portfolio holdings

AUM $47.1M
1-Year Est. Return 320.45%
This Fund
S&P 500
This Quarter Est. Return
+30.7%
1 Year Est. Return
+320.45%
3 Year Est. Return
+2,492.23%
5 Year Est. Return
+19,933.92%
10 Year Est. Return
AUM
$356M
AUM Growth
-$31.2M
Cap. Flow
-$69.9M
Cap. Flow %
-19.65%
Top 10 Hldgs %
18.36%
Holding
216
New
41
Increased
27
Reduced
12
Closed
135

Top Buys

Rank Stock Value
1
PERI icon
Perion Network
PERI
+$5.36M
2
RIG icon
Transocean
RIG
+$4.94M
3
WYNN icon
Wynn Resorts
WYNN
+$4.85M
4
LECO icon
Lincoln Electric
LECO
+$4.8M
5
ATI icon
ATI
ATI
+$4.61M

Sector Composition

Rank Sector Weight
1 Industrials 30.49%
2 Technology 24.32%
3 Consumer Discretionary 15.04%
4 Healthcare 15%
5 Financials 5.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMBT
201
CMB.TECH NV
CMBT
$4.71B
-166,860
Closed -$2.84M
AZPN
202
DELISTED
Aspen Technology Inc
AZPN
-5,982
Closed -$1.23M
HAYN
203
DELISTED
Haynes International, Inc.
HAYN
-34,117
Closed -$1.56M
CHUY
204
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
-52,556
Closed -$1.49M
SILK
205
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
-35,135
Closed -$1.86M
MODN
206
DELISTED
MODEL N, INC.
MODN
-50,007
Closed -$2.03M
ERF
207
DELISTED
Enerplus Corporation
ERF
-279,324
Closed -$4.93M
CBAY
208
DELISTED
Cymabay Therapeutics
CBAY
-311,808
Closed -$1.96M
AVTA
209
DELISTED
Avantax, Inc. Common Stock
AVTA
-82,133
Closed -$2.1M
TWNK
210
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
-107,370
Closed -$2.41M
KDNY
211
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-66,787
Closed -$1.75M
DICE
212
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
-36,420
Closed -$1.14M
BLU
213
DELISTED
BELLUS Health Inc.
BLU
-92,884
Closed -$760K
RXDX
214
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-22,893
Closed -$2.52M
PRVB
215
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-209,856
Closed -$2.22M
INBX
216
DELISTED
Inhibrx, Inc. Common Stock
INBX
-44,524
Closed -$1.1M

Similar funds

EAM Global Investors's Q1 2023 Portfolio in Review

As of Q1 2023, EAM Global Investors held 216 positions worth $356M, down 8.1% from $387M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

EAM Global Investors withdrew a net $69.9M in Q1 2023, closing 135 positions and reducing 12 holdings. Its most notable exit was Xenon Pharmaceuticals, an estimated $5.77M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EAM Global Investors opened a new position in Perion Network worth $6.38M.

  • EAM Global Investors's largest Q1 2023 buy was Perion Network: 161,132 shares worth $6.38M.
  • EAM Global Investors added most to Iridium Communications in Q1 2023, an estimated $3.46M increase.
  • EAM Global Investors's biggest Q1 2023 reduction was Viemed Healthcare, cutting an estimated $2.49M.
  • EAM Global Investors fully exited Xenon Pharmaceuticals in Q1 2023, selling an estimated $5.77M.
  • EAM Global Investors's ten largest holdings make up 18% of its $356M portfolio in Q1 2023.
  • EAM Global Investors opened 41 new positions and closed 135 in Q1 2023.
  • EAM Global Investors's portfolio value fell 8.1% quarter-over-quarter to $356M.

Based on EAM Global Investors's 13F filing for Q1 2023, filed 15 May 2023.